Breaking News Headlines Today

News from Cardiac Interventions Today

See all of Cardiac Interventions Today news coverage in one place. Discover how Cardiac Interventions Today’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 29 have been published by Cardiac Interventions Today which Ground News has aggregated in the past 3 months.

The Ground News media bias check for Cardiac Interventions Today is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Cardiac Interventions Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Cardiac Interventions Today

Where is Cardiac Interventions Today located?Cardiac Interventions Today's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Cardiac Interventions Today News

Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

100% Center coverage: 1 sources

(MedPage Today) -- The inflammation suppressant colchicine could show more promise in transcatheter aortic valve replacement (TAVR) -- if not for excess strokes, as seen in one small randomized study. In the Co-STAR double-blind trial, periprocedural...See the Story

Maryland · Maryland

XyloCor Begins EXACT-2 Trial of Catheter-Based XC001 Gene Therapy to Treat of CAD - Cardiac Interventions Today

July 25, 2025—XyloCor Therapeutics, a biopharmaceutical company developing therapies for cardiovascular disease, recently announced the first patient has been enrolled in the EXACT-2 trial. The phase 2b, multicenter, randomized, double-blind study is evaluating the company’s catheter-based gene therapy candidate XC001 (encoberminogene rezmadenovec) in patients with coronary artery disease and refractory angina. EXACT-2, which is composed of 100 …Read Article

Albany, New York · Albany

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).The post First subject enrolled in trial of Medtronic’s liquid embolic system appeared first on Medical Device Network.See the Story

Results of DECIDE registry presented at SCCT 2025 - Cardiovascular News

Heartflow has announced new data for its artificial intelligence (AI)-enabled Heartflow Plaque Analysis, including final primary endpoint data from the DECIDE registry. Data from the DECIDE registry showed Heartflow Plaque Analysis led to medical management change in over half of patients beyond coronary computed tomography angiography (CCTA) alone, regardless of traditional risk factors or CCTA findings. The DECIDE registry is the largest prosp…Artificial Intelligence · Montreal See the Story

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

July 17, 2025—Biosensors International recently announced it received CE Mark certification for the Imperia delivery system under the European Union Medical Device Regulation 2017/745. The Imperia device is now commercially available across Europe. According to the company, the Imperia device is part of the Biosensors Allegra self-expanding, supra-annular, transcatheter heart valve (THV). Allegra is intended for transfemoral implantation of the …Maryland · Maryland Read Article

Abbott gains national CMS coverage for tricuspid valve repair

100% Center coverage: 1 sources

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid regurgitation, in which blood can leak backward into the heart.United States · United States See the Story

Medtronic’s SPYRAL GEMINI Multiorgan Denervation Study Begins Enrollment - Cardiac Interventions Today

July 7, 2025—Medtronic announced that the first patient has been treated in its SPYRAL GEMINI global pilot study, which will investigate the safety and potential efficacy of multiorgan denervation (MDN) in patients with uncontrolled hypertension (HTN). According to the company, the SPYRAL GEMINI pilot program is intended to evaluate the feasibility of combined denervation of both the renal and common hepatic arteries with the company’s Symplicit…Maryland · Maryland Read Article

First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease - Cardiovascular News

Boston Scientific’s global headquarters in Marlborough, USA The first US procedures have been performed in the FRACTURE investigational device exemption (IDE) trial of the Bolt intravascular lithotripsy (IVL) system in patients undergoing percutaneous coronary intervention (PCI) for the treatment of coronary artery disease in severely calcified lesions. Brian K Jefferson, a physician at TriStar Centennial Medical Center (Nashville, USA) and inve…Nashville, Tennessee · Nashville See the Story

Evoque tricuspid valve replacement system gains Health Canada approval - Cardiovascular News

Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system. Edwards Lifesciences has announced that the company’s Evoque tricuspid valve replacement system has received Health Canada’s approval for the treatment of tricuspid regurgitation (TR). The Evoque system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is …Health Canada · Toronto See the Story

Inquis’ Aventus Thrombectomy System Cleared to Treat PE - Cardiac Interventions Today

June 16, 2025—Inquis Medical announced that its Aventus mechanical thrombectomy system has received FDA 510(k) clearance for an expanded indication to treat pulmonary embolism (PE). The device was previously cleared by the FDA for use in the peripheral vasculature. According to Inquis, the Aventus system incorporates the company’s tissue-sensing technology to help physicians distinguish the type of tissue in contact with the catheter tip in real…Maryland · Maryland See the Story

TRANSFORM II study of sirolimus DCB completes patient enrolment - Cardiovascular News

Enrolment has been completed in the TRANSFORM II randomised controlled trial, comparing the MagicTouch (Concept Medical) sirolimus drug-coated balloon (DCB) to an everolimus drug-eluting stent (DES) in treating de-novo coronary lesions. TRANSFORM II is an investigator-initiated trial sponsored by Fondazione Ricerca e Innovazione Cardiovascolare (RIC) in Milan, Italy, taking place in 52 centres across Europe, Asia and South America. A total of 1,…Milan, Lombardy · Milan See the Story

News from Cardiac Interventions Today

News from Cardiac Interventions Today

Information about Cardiac Interventions Today

Media Bias Ratings

Factuality

Ownership

Top Cardiac Interventions Today News

Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

XyloCor Begins EXACT-2 Trial of Catheter-Based XC001 Gene Therapy to Treat of CAD - Cardiac Interventions Today

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Results of DECIDE registry presented at SCCT 2025 - Cardiovascular News

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

Abbott gains national CMS coverage for tricuspid valve repair

Medtronic’s SPYRAL GEMINI Multiorgan Denervation Study Begins Enrollment - Cardiac Interventions Today

First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease - Cardiovascular News

Evoque tricuspid valve replacement system gains Health Canada approval - Cardiovascular News

Inquis’ Aventus Thrombectomy System Cleared to Treat PE - Cardiac Interventions Today

TRANSFORM II study of sirolimus DCB completes patient enrolment - Cardiovascular News

Similar News Topics

Topics Most Covered by Cardiac Interventions Today

Sources Covering Similar Topics

Breaking News Topics Related to Cardiac Interventions Today

Information about Cardiac Interventions Today

Media Bias Ratings

Factuality

Ownership

Results of DECIDE registry presented at SCCT 2025 - Cardiovascular News

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

Abbott gains national CMS coverage for tricuspid valve repair

Medtronic’s SPYRAL GEMINI Multiorgan Denervation Study Begins Enrollment - Cardiac Interventions Today

First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease - Cardiovascular News

Evoque tricuspid valve replacement system gains Health Canada approval - Cardiovascular News

Inquis’ Aventus Thrombectomy System Cleared to Treat PE - Cardiac Interventions Today

TRANSFORM II study of sirolimus DCB completes patient enrolment - Cardiovascular News